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Research on the lymphatic vascular system has made relatively slow progress compared to that of the blood
vascular system. The major reasons for this include a lack of reliable techniques for the identification of lym-
phatic vessels in tissue, and that blood circulation is considered to be directly connected with life, and therefore
requires urgent investigation of associated pathogenesis and treatments. However, in recent decades, research
on the lymphatic system has made remarkably rapid progress because of the discovery of specific markers for
lymphatic endothelial cells, various factors and genes relating to their proliferation and regeneration, and also sig-
nificant advancements in lymphatic vessel imaging techniques. We have entered a new era of lymphatic system
studies in both basic and clinical research fields. The importance of lymphatic vessels in local microcirculation is
being realized through improved understanding of the functional significance of the lymphatic system in the nor-
mal body fluid circulation, and its contribution to defense against various infections and cancers. The establish-
ment of treatments for lymphatic diseases relating to edema (lymphedema), immune disorders including organ
transplantation, and lymphogenic metastasis of malignant tumors is a matter of great urgency. In the present re-
view, I present the phylogeny, ontogeny, and mechanisms for lymphangiogenesis/lymphvasculogenesis, and re-
port some important disorders relating to lymphangiogenesis, and discuss promising recently published strate-
gies for their treatment.
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Fig.　1　Generalized schematic of body fluid circulation
Long solid arrows show blood flow in the blood vascular system. Dotted arrows show 
lymph flow in the lymphatic system. Smaller arrows show bidirectional exchanges of body 






















































Fig.　2　Origin of vascular systems and relationship between the myelopoietic and lympho-
poietic systems in association with the primitive gut
A: The vascular system is formed as a network in the inter-dermal areas (＊), where 
body fluid can flow freely. Blood vessels form vascular networks in these areas. B: Dis-
tribution of myelopoietic system (dotted) and lymphopoietic system (slashed) against for-
eign objects ingested into the primitive gut. The former consists of primary myelopoietic 
organs (e.g. blood island, liver) on the ventral side of the primitive gut and secondary 
myelopoietic organs (e.g. spleen) on the dorsal side. The latter consists of primary lym-
phopoietic organs (primitive thymus at the entrance of the primitive gut, bursa of Fabri-
cius in the cloaca at the end) and secondary lymphopoietic organs (e.g. spleen, Peyer’s 
patches, lymph nodes) along the intestine.































Fig.　3　Changes in fat flow across liver phylogeny and sources of the hepatic portal vein 
during ontogenesis
A-top: In aquatic organisms, fat (dotted) as well carbohydrates and proteins are trans-
ported via the portal vein (1V) to the liver. The fat is stored in the liver as “cod liver 
oil”．A-bottom: In terrestrial organisms, fat (dotted) is only absorbed by the lacteals and 
transported via the thoracic duct to the general blood circulation without first accumu-
lating in the liver. The portal vein (2V) only transports carbohydrates and proteins to the 
liver. In the human liver, fat storing cells known as Ito’s fat storing cells are only located 
in the space of Disse. B: During ontogenesis, the mammalian hepatic portal vein chrono-
logically originates from the yolk sac (1), placenta (2), and, after birth, the digestive tract (3). 
The ductus venosus ( ★ ) and ductus arteriosus (＊) are represented.















Fig.　4　Phylogeny of the lymphatic system and lymph hearts in various species
A: The thoracic duct (T) enveloping the aorta (Ao) of a snake. A valve equipped with 
smooth muscle fibers is indicated by an arrow. B: The lymph heart of a lizard. A valve 
with smooth muscle fibers (arrow) can be seen at the entrance of the lymph heart filled 
with Berline blue. C: The lymph hearts of salamanders ( ① ), frogs ( ② ), snakes ( ③ ), and 


































Table　1　Specific markers for lymphatic endothelial cells
Marker Species Location Molecular size(kDa) Function Representative references＊
CD73 human cell surface 69 adhesion, 5’-nucleotidase Thompson et al. (1989)48)
B27 rat cytoplasm ? ? Ezaki et al. (1990)49)
VEGFR-3 (Flt4) mouse cell surface 170 VEGF-C receptor Kaipainen et al. (1995)15)
Prox-1 mouse nucleus 85-95 transcription factor Wigle and Oliver (1999)50)
LYVE-1 mouse, human cell surface 60 hyaluronan receptor Banerji et al. (1999)28),
Prevo et al. (2001)51)
Podoplanin mouse cell surface 43 platelet aggregation Schacht et al. (2003)52)
Foxc-2 mouse nucleus 54-63 transcription factor Petrova et al. (2004)53)
D2-40 human cell surface 40 human podoplanin Kahn et al. (2002)54),
Schacht et al (2005)55)
LA102 mouse cell surface 25-27 ( ≒ mouse CD90?) Ezaki et al. (2006)56)


































































Table　2　Differences in gene profiles between lymphatic endothelial cells (LEC) and blood vessel endo-
thelial cells (BEC)
Categories BEC LEC













Desmoplakin I and II
Adducin γ
Plakoglobin
α-actinin-2 associated LIM protein





Extracellular matrix modulation MMP-1, MMP-14
uPA
Plasminogen activator inhibitor I
Cathepsin C
TIMP-3
Cytokines, chemokines & receptors IL-8, IL-6



































皮増殖因子（vascular endothelial growth factor：
VEGF）とその受容体群が発見されてからである．リ
ンパ管新生研究の幕開けとなったのも，VEGF 受容
体ファミリーの 1 つである VEGFR3 の発見２１）と，こ
れがリンパ管内皮細胞に特異的に発現すること１５），
ならびに VEGFR3 のリガンドとしての VEGF-C が
リンパ管新生因子であること２２）が報告されたことで
あった．さらに，血管内皮細胞との関係で対比され
る分子として，neuropilin-2 の KO マウスで皮下にリ
ンパ管が欠損して浮腫を起こすこと２３），また















Fig.　5　The process of lymphatic endothelial cell differentiation from venous endothelial 
cells, and related target genes expressed at each step in mice
At the embryonic stage of 8.5 days (E8.5), venous differentiation occurs with coinciding 
high expression of VEGFR2. At E9.5 ～ E12.5 some venous endothelial cells become posi-
tive for LYVE-1 and Sox18, and acquire the ability to differentiate into lymphatic vessels. 
The expression of Sox18 induces the expression of Prox1, a master control gene in the 
process of lymphatic endothelial cell differentiation. The expression of Prox1 induces its 
target genes, such as VEGFR3 (a receptor for VEGF-C), and podoplanin, which increases 
cell mobility. Prox1 also temporally suppresses VE-cadherin, enabling free migration, so 
that the cells can detach from each other and move towards VEGF-C to form a stable 
lymphatic vessel.
核内受容体でもある chicken ovalbumin upstream
promoter transcription factor II（COUP-TF II）とい








られている．ここで，Sry-related HMG box family
転写因子である Sox18 が発現するようになると，既
に静脈内皮で発現していた COUP-TF II と共役し

















には forkhead box protein C2（Foxc2），nuclear fac-
tor of activated T-cells cytoplasmic 1（NFATc1），
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